US EditionSam Altman to invest in Merge Labs in bid to outdo Elon Musk’s Neuralink
Merge Labs aims to develop less invasive brain-computer interfaces and is valued at $850 million, targeting $250 million in funding primarily from OpenAI's venture arm, challenging Neuralink's $9 billion valuation.
- Sam Altman plans to invest in Merge Labs, which aims to compete with Elon Musk's Neuralink in connecting human brains to computers.
- Merge Labs is working to raise $250 million at an $850 million valuation, with significant funds expected from OpenAI.
- Altman will help launch Merge Labs but will not have a day-to-day role in the project.
- Neuralink has secured $650 million this year and aims to complete over 20 brain-computer interface trials.
48 Articles
48 Articles
Sam Altman to Launch Merge Labs, Taking Direct Aim at Musk’s Neuralink - American Faith
OpenAI CEO Sam Altman is co-founding Merge Labs, a brain-computer interface startup positioned to compete directly with Elon Musk’s Neuralink. According to The Financial Times, the company plans to raise $250 million at an $850 million valuation, with a large portion of its funding expected from OpenAI’s ventures arm. Altman, who launched OpenAI alongside Musk in 2015 before Musk left its board in 2018, will partner with Alex Blania, the founder…
OpenAI's Sam Altman Will Back a Creepy Brain Chip Company to Challenge Elon Musk's Neuralink
OpenAI boss Sam Altman is preparing to back a new company called Merge Labs that will compete with Elon Musk's Neuralink in connecting human brains with computers. The post OpenAI’s Sam Altman Will Back a Creepy Brain Chip Company to Challenge Elon Musk’s Neuralink appeared first on Breitbart.
Unreconcilable enemies in life and artificial intelligence, Elon Musk and Sam Altman will compete in another new industry, that of brain implants.
Coverage Details
Bias Distribution
- 40% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
